Product Information

GABAPENTIN 600 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0654 per EA under NDC 72888013105. Its NADAC has been published 159 times since Nov 8, 2023.

FDA first approved this application on Sep 13, 2006. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GABAPENTIN 600 MG TABLET

gabapentin
$0.0654per EA

Strength

600 mg/1

NDC

72888013105

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA077661

FDA Approved

9/13/2006

TE Code

AB1

On Market Since

9/22/2022

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 600 MG TABLET has been published 159 times since Nov 8, 2023, and over the history we have for it it has declined 32.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0654 per EA
All-time high$0.1086 (Jan 10, 2024)
All-time low$0.0602 (Nov 20, 2024)
52-week high$0.0703
52-week low$0.0638
Median price$0.0746
Average price$0.0781
Largest weekly change-36.7% (Nov 20, 2024)
Weeks tracked159
Tracking sinceNov 8, 2023

Price History

1W

+2.3%

1M

+2.3%

3M

+2.6%

6M

-4.1%

1Y

-8.1%

3Y

-32.9%

5Y

N/A

All

-32.9%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GABAPENTIN 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 600 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0654 per EA (NDC 72888013105), effective Nov 18, 2026.

How has the price of GABAPENTIN 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 600 MG TABLET has declined 32.9%. It has been tracked across 159 weekly CMS publications since Nov 8, 2023.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 600 MG TABLET?

Since Nov 8, 2023, the NADAC for GABAPENTIN 600 MG TABLET has ranged from a low of $0.0602 (Nov 20, 2024) to a high of $0.1086 (Jan 10, 2024), with a median of $0.0746 per EA.

Are there cheaper alternatives to GABAPENTIN 600 MG TABLET?

8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 600 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures GABAPENTIN 600 MG TABLET?

GABAPENTIN 600 MG TABLET (NDC 72888013105) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.